Carcinoma ex pleomorphic adenoma (CXPA): Immunoprofile of the cells involved in carcinomatous progression

Histopathology

Volumn 46, Issue 6, 2005, Pages 635-641

  Altemani, A ^a   Martins, M T ^b   Freitas, L ^a   Soares, F ^c   Araujo N S ^b   Araújo, Vera Cavalcanti ^b,d  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

Carcinoma; Immunoprofile; Pleomorphic adenoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN 14; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN 8; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOMA EX PLEOMORPHIC ADENOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL;

ACTINS; ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-14; KERATIN-7; KERATINS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 20644439556     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02157.x     Document Type: Article

References (21)

1. Livolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 1977; 39: 2209-2230.
2. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993; 28: 279-328.
3. Ellis GL, Auclair PL. Malignant epithelial tumors. In Rosai J, Sobin LH eds. Atlas of tumor pathology, Series 3. Section 5, Fascicle 17. Washington, DC: Armed Forces Institute of Pathology. 1996: 155-373.
4. Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001; 23: 705-712.
5. Felix A, Rosa-Santos J, Mendonça ME, Torrinha F, Soares J. Intracapsular carcinoma ex pleomorphic adenoma. Report of a case with unusual metastatic behavior. Oral Oncol. 2002; 38: 107-110.
6. Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors: histomorphologic indexes. Arch. Otolaryngol. 1984; 110: 172-176.
7. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum. Pathol. 2001; 32: 596-604.
8. Costa-Rosa J, Fonseca I, Felix A, Soares J. Immunohistochemical study of c-erbB-2 expression in carcinoma ex-pleomorphic adenoma. Histopathology 1996; 28: 247-252.
9. Norberg L, Stratis M, Dardick I. Quantification and localization of cycling tumor cells in pleomorphic adenomas and myoepitheliomas: an immunohistochemical analysis. Oral Pathol. Med. 1997; 26: 124-128.
10. Neureiter D, Bohmer J, Kirchner T, Aigner T. Pleomorphic adenomas of the parotid express different mesenchimal phenotypes: demonstration of matrix gene expression products characteristic of the fibroblastic and chondrocytic cell lineages. Histopathology 1999; 35: 373-379.
11. Araujo VC, Souza SO. Expression of different keratins in salivary gland tumours. Eur. J. Cancer B Oral Oncol. 1996; 32B: 14-18.
12. Araujo VC, Sousa SO, Carvalho YR, Araujo NS. Application of immunohistochemistry to the diagnosis of salivary gland tumors. Appl. Immunohistochem. Mol. Morph. 2000; 8: 195-202.
13. Sato M, Hayashi Y, Yoshida H, Yanagawa T, Yura Y, Nitta T. Search for specific markers of neoplastic epithelial duct and myoepithelial cell lines established from human salivary gland and characterization of their growth in vitro. Cancer 1984; 54: 2959-2967.
14. Jaeger MM, Araujo VC, Kachar B, Jaeger RG. Effect of spatial arrangement of the basement membrane on cultured pleomorphic adenoma cells. Study by immunocytochemistry and electron and confocal microscopy. Virchows Arch. 1997; 430: 467-477.
15. Brandwein M, Huvos A, Dardick I, Thomas JM, Theise ND. Noninvasive and minimally invasive carcinoma ex mixed tumor. A clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1996; 81: 655-664.
16. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science 1998; 279: 514-519.
17. Sternlicht MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med. Hypotheses 1997; 48: 37-46.
18. Burns BF, Dardick I, Parks WR. Intermediate filament expression in normal parotid glands and pleomorphic adenomas. Virchows Arch. 1988; 423: 103-112.
19. Draeger A, Nathrath WBJ, Lane EB, Sundström BE, Sigbrand TI. Cytokeratins, smooth muscle actin and vimentin in human normal salivary gland and pleomorphic adenomas. APMIS 1991; 99: 405-415.
20. Seifert G, Sobin LH eds. WHO international classification of tumours. Histological typing of salivary gland tumours, 2nd edn. Berlin Heidelberg: Spring-Verlag, 1991.
21. Thackray AC, Lucas RB. Carcinoma in pleomorphic adenoma. In Hartman WH ed. Atlas of tumor pathology. Series 2, Fascicle 10. Washington, DC: Armed Forces Institute of Pathology. 1974: 107-117.